Why the study?
Does ad hoc clopidogrel loading compared to pre-treatment affect platelet P-selectin expression in patients undergoing coronary stent implantation?
Does ad hoc clopidogrel loading compared to pre-treatment affect platelet P-selectin expression in patients undergoing coronary stent implantation?
Ad hoc clopidogrel loading demonstrates a beneficial effect in reducing platelet reactivity during coronary stenting.
Answers are grounded in this paper and cite their sources.
Ad hoc clopidogrel loading was associated with reduced platelet reactivity; hypothesis-generating and leaves open clinical outcomes versus pretreatment.
Stents represent a thrombogenic surface where one of the earliest events is the deposition of platelets. Activated platelets express neoepitopes that enable them to form homo- and heterotypic aggregates and activate the coagulation system. In this study, we investigated the effects of ad hoc clopidogrel treatment compared to a clopidogrel pretreated group on platelet P-selectin expression. We found that after stent implantation in the ad hoc treated group, P-selectin expression decreased after 1 h, while the initial decrease in platelet count normalized after 4 h. Aspirin non-responsiveness did not influence the results. These data point to the beneficial effect of clopidogrel treatment in reducing platelet reactivity during stenting.
No takes yet. Share an insight, caveat, or question.
Szük et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: